Literature DB >> 16651522

Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue.

Päivi Norja1, Kati Hokynar, Leena-Maija Aaltonen, Renwei Chen, Annamari Ranki, Esa K Partio, Olli Kiviluoto, Irja Davidkin, Tomi Leivo, Anna Maria Eis-Hübinger, Beate Schneider, Hans-Peter Fischer, René Tolba, Olli Vapalahti, Antti Vaheri, Maria Söderlund-Venermo, Klaus Hedman.   

Abstract

Human erythrovirus is a minute, single-stranded DNA virus causing many diseases, including erythema infectiosum, arthropathy, and fetal death. After primary infection, the viral genomes persist in solid tissues. Besides the prototype, virus type 1, two major variants (virus types 2 and 3) have been identified recently, the clinical significance and epidemiology of which are mostly unknown. We examined 523 samples of skin, synovium, tonsil, or liver (birth year range, 1913-2000), and 1,640 sera, by qualitative and quantitative molecular assays for the DNA of human erythroviruses. Virus types 1 and 2 were found in 132 (25%) and 58 (11%) tissues, respectively. DNA of virus type 1 was found in all age groups, whereas that of type 2 was strictly confined to those subjects born before 1973 (P < 0.001). Correspondingly, the sera from the past two decades contained DNA of type 1 but not type 2 or 3. Our data suggest strongly that the newly identified human erythrovirus type 2 as well as the prototype 1 circulated in Northern and Central Europe in equal frequency, more than half a century ago, whereafter type 2 disappeared from circulation. Type 3 never attained wide occurrence in this area during the past > or =70 years. The erythrovirus DNA persistence in human tissues is lifelong and represents a source of information about our past, the Bioportfolio, which, at the individual level, provides a registry of one's infectious encounters, and at the population level, a database for epidemiological and phylogenetic analyses.

Entities:  

Mesh:

Year:  2006        PMID: 16651522      PMCID: PMC1464359          DOI: 10.1073/pnas.0602259103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  53 in total

1.  Cloning of a human parvovirus by molecular screening of respiratory tract samples.

Authors:  Tobias Allander; Martti T Tammi; Margareta Eriksson; Annelie Bjerkner; Annika Tiveljung-Lindell; Björn Andersson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-23       Impact factor: 11.205

2.  Slow clearance of human parvovirus B19 viremia following acute infection.

Authors:  Anna Lindblom; Adiba Isa; Oscar Norbeck; Susanne Wolf; Bo Johansson; Kristina Broliden; Thomas Tolfvenstam
Journal:  Clin Infect Dis       Date:  2005-09-02       Impact factor: 9.079

3.  Retrospective birth dating of cells in humans.

Authors:  Kirsty L Spalding; Ratan D Bhardwaj; Bruce A Buchholz; Henrik Druid; Jonas Frisén
Journal:  Cell       Date:  2005-07-15       Impact factor: 41.582

4.  New DNA viruses identified in patients with acute viral infection syndrome.

Authors:  Morris S Jones; Amit Kapoor; Vladimir V Lukashov; Peter Simmonds; Frederick Hecht; Eric Delwart
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

5.  Persistent B19 infection in immunocompetent individuals: implications for transfusion safety.

Authors:  Jean-Jacques Lefrère; Annabelle Servant-Delmas; Daniel Candotti; Martine Mariotti; Isabelle Thomas; Yvon Brossard; François Lefrère; Robert Girot; Jean-Pierre Allain; Syria Laperche
Journal:  Blood       Date:  2005-06-23       Impact factor: 22.113

6.  Presence of DNA of human papillomavirus 16 but no other types in tumor-free tonsillar tissue.

Authors:  Renwei Chen; Peter Sehr; Tim Waterboer; Ilmo Leivo; Michael Pawlita; Antti Vaheri; Leena-Maija Aaltonen
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

7.  Detection and differentiation of human parvovirus variants by commercial quantitative real-time PCR tests.

Authors:  Kati Hokynar; Päivi Norja; Harri Laitinen; Pekka Palomäki; Antoine Garbarg-Chenon; Annamari Ranki; Klaus Hedman; Maria Söderlund-Venermo
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

8.  Parvovirus B19-induced apoptosis of hepatocytes.

Authors:  Brian D Poole; Yuory V Karetnyi; Stanley J Naides
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

9.  Latent Epstein-Barr virus (EBV) infection and cytomegalovirus (CMV) infection in synovial tissue of autoimmune chronic arthritis determined by RNA- and DNA-in situ hybridization.

Authors:  Yasmin Mehraein; Carsten Lennerz; Sandra Ehlhardt; Klaus Remberger; Andreas Ojak; Klaus D Zang
Journal:  Mod Pathol       Date:  2004-07       Impact factor: 7.842

10.  Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry.

Authors:  Kirsten A Weigel-Kelley; Mervin C Yoder; Arun Srivastava
Journal:  Blood       Date:  2003-08-07       Impact factor: 22.113

View more
  88 in total

Review 1.  From orphan virus to pathogen: the path to the clinical lab.

Authors:  Linlin Li; Eric Delwart
Journal:  Curr Opin Virol       Date:  2011-10       Impact factor: 7.090

2.  Biological and immunological relations among human parvovirus B19 genotypes 1 to 3.

Authors:  Anna Ekman; Kati Hokynar; Laura Kakkola; Kalle Kantola; Lea Hedman; Heidi Bondén; Matthias Gessner; Claudia Aberham; Päivi Norja; Simo Miettinen; Klaus Hedman; Maria Söderlund-Venermo
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

3.  Myocardial parvovirus B19 persistence: lack of association with clinicopathologic phenotype in adults with heart failure.

Authors:  Garrick C Stewart; Javier Lopez-Molina; Raju V S R K Gottumukkala; Gregg F Rosner; Mary S Anello; Jonathan L Hecht; Gayle L Winters; Robert F Padera; Kenneth L Baughman; Myra A Lipes
Journal:  Circ Heart Fail       Date:  2010-11-19       Impact factor: 8.790

4.  Comparative analysis reveals frequent recombination in the parvoviruses.

Authors:  Laura A Shackelton; Karin Hoelzer; Colin R Parrish; Edward C Holmes
Journal:  J Gen Virol       Date:  2007-12       Impact factor: 3.891

Review 5.  Heterogeneous pathways of maternal-fetal transmission of human viruses (review).

Authors:  A Saleh Younes; Márta Csire; Beatrix Kapusinszky; Katalin Szomor; Mária Takács; György Berencsi
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

Review 6.  The MOGE(S) classification for cardiomyopathies: current status and future outlook.

Authors:  Julian G Westphal; Angelos G Rigopoulos; Constantinos Bakogiannis; Sarah E Ludwig; Sophie Mavrogeni; Boris Bigalke; Torsten Doenst; Matthias Pauschinger; Carsten Tschöpe; P Christian Schulze; Michel Noutsias
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

7.  Molecular phenotypes of human parvovirus B19 in patients with myocarditis.

Authors:  C-Thomas Bock; Anja Düchting; Friederike Utta; Eva Brunner; Bui Tien Sy; Karin Klingel; Florian Lang; Meinrad Gawaz; Stephan B Felix; Reinhard Kandolf
Journal:  World J Cardiol       Date:  2014-04-26

8.  A newly identified bocavirus species in human stool.

Authors:  Amit Kapoor; Elizabeth Slikas; Peter Simmonds; Thaweesak Chieochansin; Asif Naeem; Shahzad Shaukat; Muhammad Masroor Alam; Salmaan Sharif; Mehar Angez; Sohail Zaidi; Eric Delwart
Journal:  J Infect Dis       Date:  2009-01-15       Impact factor: 5.226

9.  Multiple diverse circoviruses infect farm animals and are commonly found in human and chimpanzee feces.

Authors:  Linlin Li; Amit Kapoor; Beth Slikas; Oderinde Soji Bamidele; Chunlin Wang; Shahzad Shaukat; Muhammad Alam Masroor; Michael L Wilson; Jean-Bosco N Ndjango; Martine Peeters; Nicole D Gross-Camp; Martin N Muller; Beatrice H Hahn; Nathan D Wolfe; Hinda Triki; Joanne Bartkus; Sohail Zahoor Zaidi; Eric Delwart
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

10.  Frequent cross-species transmission of parvoviruses among diverse carnivore hosts.

Authors:  Andrew B Allison; Dennis J Kohler; Karen A Fox; Justin D Brown; Richard W Gerhold; Valerie I Shearn-Bochsler; Edward J Dubovi; Colin R Parrish; Edward C Holmes
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.